AstraZeneca Current Ratio 2006-2019 | AZN

Current and historical current ratio for AstraZeneca (AZN) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. AstraZeneca current ratio for the three months ending June 30, 2019 was 0.95.
AstraZeneca Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $15.22B $16.03B 0.95
2019-03-31 $13.65B $18.26B 0.75
2018-12-31 $15.59B $16.29B 0.96
2018-09-30 $13.11B $15.25B 0.86
2018-06-30 $12.45B $17.20B 0.72
2018-03-31 $13.18B $18.16B 0.73
2017-12-31 $13.15B $16.38B 0.80
2017-09-30 $13.63B $14.46B 0.94
2017-06-30 $14.30B $15.66B 0.91
2017-03-31 $11.64B $15.43B 0.75
2016-12-31 $13.26B $15.26B 0.87
2016-09-30 $12.87B $15.38B 0.84
2016-06-30 $13.32B $14.34B 0.93
2016-03-31 $12.77B $15.93B 0.80
2015-12-31 $16.01B $14.87B 1.08
2015-09-30 $13.20B $16.04B 0.82
2015-06-30 $13.81B $16.15B 0.86
2015-03-31 $12.69B $15.76B 0.81
2014-12-31 $16.70B $17.33B 0.96
2014-09-30 $15.07B $15.82B 0.95
2014-06-30 $16.20B $16.32B 0.99
2014-03-31 $16.54B $17.51B 0.95
2013-12-31 $20.34B $16.05B 1.27
2013-09-30 $18.79B $14.68B 1.28
2013-06-30 $19.39B $15.20B 1.28
2013-03-31 $18.34B $13.86B 1.32
2012-12-31 $19.05B $13.90B 1.37
2012-09-30 $18.03B $14.13B 1.28
2012-06-30 $19.78B $14.80B 1.34
2012-03-31 $21.56B $15.80B 1.37
2011-12-31 $23.51B $15.75B 1.49
2011-09-30 $22.47B $14.66B 1.53
2011-06-30 $22.69B $13.84B 1.64
2011-03-31 $23.47B $16.02B 1.47
2010-12-31 $25.13B $16.79B 1.50
2010-09-30 $24.57B $16.85B 1.46
2010-06-30 $23.38B $16.30B 1.43
2010-03-31 $22.35B $16.99B 1.32
2009-12-31 $23.76B $17.64B 1.35
2009-09-30 $20.54B $15.12B 1.36
2009-06-30 $19.13B $15.14B 1.26
2009-03-31 $15.85B $14.05B 1.13
2008-12-31 $16.15B $13.32B 1.21
2008-09-30 $15.60B $14.38B 1.09
2008-06-30 $16.59B $15.99B 1.04
2008-03-31 $14.69B $15.68B 0.94
2007-12-31 $17.08B $15.19B 1.13
2007-09-30 $0.00B 0.00
2007-06-30 $16.08B $24.93B 0.65
2007-03-31 $16.29B $10.35B 1.57
2006-12-31 $16.94B $9.45B 1.79
2006-09-30 $14.43B $8.09B 1.78
2006-06-30 $15.05B $8.41B 1.79
2006-03-31 $13.51B $7.14B 1.89
2005-12-31 $13.77B $6.84B 2.01
2005-09-30 $13.10B $6.74B 1.94
2005-06-30 $13.44B $6.80B 1.98
2005-03-31 $12.70B $6.84B 1.86
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $112.309B $22.090B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $346.681B 15.10
Roche Holding AG (RHHBY) Switzerland $237.118B 0.00
Merck (MRK) United States $217.785B 17.91
Novartis AG (NVS) Switzerland $205.270B 17.65
Pfizer (PFE) United States $191.651B 11.29
Novo Nordisk (NVO) Denmark $126.560B 21.00
Eli Lilly (LLY) United States $106.700B 19.91
Sanofi (SNY) France $104.896B 12.93
GlaxoSmithKline (GSK) United Kingdom $99.695B 12.60
AbbVie (ABBV) United States $95.259B 7.63
Bristol-Myers Squibb (BMY) United States $76.848B 10.90
Bayer (BAYRY) Germany $66.954B 9.76
H Lundbeck (HLUYY) Denmark $8.015B 11.57